Darifenacin
http://dbpedia.org/resource/Darifenacin an entity of type: Thing
Darifenacin ist eine organisch-chemische Verbindung aus der Klasse der Aromaten, die unter dem Handelsnamen Emselex® (Hersteller Novartis) als Arzneistoff zur Behandlung von Harninkontinenz eingesetzt wird.
rdf:langString
Darifenacin (trade name Enablex in United States and Canada, Emselex in the European Union) is a medication used to treat urinary incontinence due to an overactive bladder. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010, the US rights were sold to Warner Chilcott for US$400 million.
rdf:langString
Daryfenacyna (łac. Darifenacinum) – bloker receptorów muskarynowych M3, stosowany w leczeniu zaburzeń czynnościowych pęcherza moczowego.
rdf:langString
rdf:langString
Darifenacin
rdf:langString
Darifenacin
rdf:langString
Daryfenacyna
xsd:integer
5310859
xsd:integer
1095938462
rdf:langString
BD10
rdf:langString
G04
xsd:integer
15
xsd:integer
28
xsd:integer
133099
xsd:integer
391960
xsd:integer
1346
xsd:integer
392054
rdf:langString
DB00496
<second>
68400.0
rdf:langString
Kidney and biliary
xsd:integer
30
rdf:langString
Darifenacin-hydrobromide-from-xtal-2009-CM-3D-balls.png
rdf:langString
as salt
xsd:integer
-2
rdf:langString
D01699
rdf:langString
D03654
rdf:langString
POM
rdf:langString
Rx-only
rdf:langString
a605039
rdf:langString
Liver
xsd:integer
2
xsd:integer
2
rdf:langString
C
xsd:integer
444031
rdf:langString
O=CC[C@H]3CNCCc5cc4ccc5
xsd:integer
1
rdf:langString
HXGBXQDTNZMWGS-RUZDIDTESA-N
rdf:langString
Enablex, Emselex
rdf:langString
APG9819VLM
rdf:langString
changed
xsd:integer
460773728
rdf:langString
changed
rdf:langString
Darifenacin ist eine organisch-chemische Verbindung aus der Klasse der Aromaten, die unter dem Handelsnamen Emselex® (Hersteller Novartis) als Arzneistoff zur Behandlung von Harninkontinenz eingesetzt wird.
rdf:langString
Darifenacin (trade name Enablex in United States and Canada, Emselex in the European Union) is a medication used to treat urinary incontinence due to an overactive bladder. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010, the US rights were sold to Warner Chilcott for US$400 million.
rdf:langString
Daryfenacyna (łac. Darifenacinum) – bloker receptorów muskarynowych M3, stosowany w leczeniu zaburzeń czynnościowych pęcherza moczowego.
xsd:integer
321
rdf:langString
S4
rdf:langString
Rx-only
rdf:langString
B3
<perCent>
98.0
xsd:float
15.0
xsd:nonNegativeInteger
6170
rdf:langString
Enablex, Emselex
xsd:string
133099-04-4
xsd:string
391960
xsd:string
1346
xsd:string
DB00496
xsd:string
APG9819VLM
xsd:string
D01699
D03654
xsd:string
a605039
xsd:string
444031